Vascular endothelial growth factor: Potential predictor of treatment response in major depression
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vascular endothelial growth factor: Potential predictor of treatment response in major depression
Authors
Keywords
-
Journal
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
Volume 18, Issue 8, Pages 575-585
Publisher
Informa UK Limited
Online
2016-01-05
DOI
10.3109/15622975.2015.1117655
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment-Resistant Depression in Primary Care across Canada
- (2017) Sakina J Rizvi et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
- (2015) Paul E. Greenberg et al. JOURNAL OF CLINICAL PSYCHIATRY
- Depression and BMI influences the serum vascular endothelial growth factor level
- (2014) Betina Elfving et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Vascular Endothelial Growth Factor: A potential diagnostic biomarker for major depression
- (2014) Anne Clark-Raymond et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy
- (2013) A. Minelli et al. ACTA PSYCHIATRICA SCANDINAVICA
- Plasma brain-derived neurotrophic factor and prefrontal white matter integrity in late-onset depression and normal aging
- (2013) R. B. Dalby et al. ACTA PSYCHIATRICA SCANDINAVICA
- VEGF plasma level variations in duloxetine-treated patients with major depression
- (2013) Michele Fornaro et al. JOURNAL OF AFFECTIVE DISORDERS
- VEGF and depression: A comprehensive assessment of clinical data
- (2013) Anne Clark-Raymond et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Vascular endothelial growth factor gene (VEGFA) polymorphisms may serve as prognostic factors for recurrent depressive disorder development
- (2013) Piotr Gałecki et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Hippocampal Angiogenesis and Progenitor Cell Proliferation Are Increased with Antidepressant Use in Major Depression
- (2012) Maura Boldrini et al. BIOLOGICAL PSYCHIATRY
- Vascular endothelial growth factor receptor 2 gene (KDR) polymorphisms and expression levels in depressive disorder
- (2012) Piotr Gałecki et al. JOURNAL OF AFFECTIVE DISORDERS
- Peripheral vascular endothelial growth factor level is associated with antidepressant treatment response: Results of a preliminary study
- (2012) Zsuzsa Halmai et al. JOURNAL OF AFFECTIVE DISORDERS
- Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system
- (2012) L.A. Carvalho et al. JOURNAL OF AFFECTIVE DISORDERS
- Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters
- (2012) J Isung et al. Translational Psychiatry
- Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): A pilot study
- (2011) Lobna Ibrahim et al. BRAIN RESEARCH BULLETIN
- VEGF regulates antidepressant effects of lamotrigine
- (2011) Rongju Sun et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders
- (2011) Bun-Hee Lee et al. JOURNAL OF AFFECTIVE DISORDERS
- Investigation of circulating endothelial progenitor cells and angiogenic and inflammatory cytokines during recovery from an episode of major depression
- (2011) Peter Dome et al. JOURNAL OF AFFECTIVE DISORDERS
- Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients
- (2011) Alessandra Minelli et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Low plasma vascular endothelial growth factor (VEGF) associated with completed suicide
- (2011) Josef Isung et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial
- (2010) Michael Liebowitz et al. DEPRESSION AND ANXIETY
- Plasma levels of vascular endothelial growth factor and fibroblast growth factor 2 in patients with major depressive disorders
- (2010) M. Takebayashi et al. JOURNAL OF NEURAL TRANSMISSION
- Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression
- (2010) Merja Viikki et al. NEUROSCIENCE LETTERS
- Differential brain, but not serum VEGF levels in a genetic rat model of depression
- (2010) Betina Elfving et al. NEUROSCIENCE LETTERS
- Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder
- (2009) Michael Bauer et al. JOURNAL OF CLINICAL PSYCHIATRY
- Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder
- (2009) Andrew J. Cutler et al. JOURNAL OF CLINICAL PSYCHIATRY
- Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder
- (2009) Shih-Jen Tsai et al. PSYCHIATRY RESEARCH
- Circulating endothelial progenitor cells and depression: a possible novel link between heart and soul
- (2008) P Dome et al. MOLECULAR PSYCHIATRY
- VEGF serum levels in depressed patients during SSRI antidepressant treatment
- (2008) Mariacarla Ventriglia et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Angiogenic factors in patients with current major depressive disorder comorbid with borderline personality disorder
- (2008) Kai G. Kahl et al. PSYCHONEUROENDOCRINOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started